2 studies were found.

1.		Completed	A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals Condition: HIV Infections
2.		Terminated	The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection Condition: HIV Infections